Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04870112
Brief Title: A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCope-D1)

First Submitted : April 16, 2021
First Submitted that Met QC Criteria : April 30, 2021
First Posted : May 3, 2021

Last Update Submitted that Met QC Criteria : September 10, 2021
Last Update Posted : September 13, 2021